Last deal

$6M

Amount

Venture - Series Unknown

Stage

06.02.1992

Date

2

all rounds

$6M

Total amount

date founded

Financing round

General

About Company
Metra Biosystems develops and sells diagnostic products for metabolic bone and joint diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.1990

founders

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

Metra Biosystems develops and commercializes diagnostic products for the detection and management of metabolic bone and joint diseases and disorders.
Contacts
Similar Companies
1000
SOMAprobes

SOMAprobes

Somaprobes develops and commercializes diagnostic tests for detecting difficult-to-diagnose diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Donostia-San Sebastian, Gipuzkoa, Spain

total rounds

3

total raised

$1.55M
GenQual Corporation

GenQual Corporation

GenQual Corporation develops biomarker diagnostics for early disease detection and diagnosis.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Des Moines, IA, USA

total rounds

1

total raised

$122K
Akonni Biosystems

Akonni Biosystems

Akonni Biosystems develops and manufactures genetic testing devices for complex infectious and human health diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Frederick, MD, USA

total rounds

15

total raised

$57.31M
Theradiag

Theradiag

Theradiag develops and markets biological diagnostic tools.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Manufacturing

Location

Marne-la-Vallée, 77420 Champs-sur-Marne, France

total rounds

4

total raised

$21.2M
M&A Details
1

Transaction name

Acquired by

Quidel

announced date

07.06.1999

price

$22.9M

Financials

Funding Rounds
2
2

Number of Funding Rounds

$6M

Money Raised

Their latest funding was raised on 06.02.1992. Their latest investor Asset Management Company. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
06.02.1992
5
$6M
06.02.1992
4
Co-Investors
Investors
6
0

Number of lead investors

6

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
No
Venture - Series Unknown
No
Venture - Series Unknown
Asset Management Company

Asset Management Company

Asset Management Company partners with entrepreneurs to create valuable new companies and industries.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Palo Alto, CA, USA

count Of Investments

18

count Of Exists

6
IVP

IVP

IVP is a venture capital firm investing in rapidly-growing technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

Menlo Park, CA, USA

count Of Investments

311

count Of Exists

94
Aperture Venture Partners

Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused on investing in the healthcare and healthy living industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital

Location

New York, NY, USA

count Of Investments

43

count Of Exists

12

People

Founders
1
Larry Bock
Larry Bock

Larry Bock

Larry Bock is the founder and organizer of the USA Science & Engineering Festival, and a former founder of the San Diego Science Festival. Mr. Bock is a Special Limited Partner to Lux Capital, a $100M nanotechnology-focused venture capital fund. He is a member of the Board of Directors of FEI Corporation (NASDAQ: FEIC), the leading supplier of tools for nanotechnology research. He is a General Partner of CW Ventures, a $100M life sciences venture capital fund. Mr. Bock was the founder and former executive chairman and initial CEO of Nanosys and the founder and initial CEO of Neurocrine Biosciences (NASDAQ: NBIX), Pharmacopeia (NASDAQ: PCOP), GenPharm International, which was acquired by Medarex for $100 million; Caliper Technologies (NASDAQ: CALP); Illumina Technologies (NASDAQ: ILMN), among numerous other firms. He was also a seed or early-stage investor in variety of firms, including Acceleron Pharma, Aurora Biosciences, Biosym Technologies, ekoVenture. Gen-Probe, Gensia Pharmaceuticals, Genocea Biosciences, IDEC Pharmaceuticals Magen Biosciences, Oclassen Pharmaceuticals Plexikon Pharmaceuticals, Poland Partners, Sequana Therapeutics, Sapphire Energy, Siluria, Sirtris Pharmaceuticals, Software Transformation, and Viagene. Mr. Bock started his career as a researcher in the early days at Genentech, the field of infectious diseases, where he was on the team that received the AAAS Newcomb Cleveland Prize for demonstrating the world’s first recombinant DNA vaccine. He was a Venture Capital Associate with Fairfield Ventures (now Oxford Bioventures). Larry and his wife, Diane, established the Larry and Diane Bock Chair in Nanotechnology at the University of California, Berkeley. They also founded Community Cousins, a non-profit foundation focused on breaking down racial barriers, that was selected by former Vice President Al Gore as one of 10 outstanding grass root efforts nationally. Larry is organizing the San Diego Science Festival with BioBridge of UCSD. He works extensively with the Sudanese and Burmese refugee’s networks in San Diego and is a tutor in math and sciences for Sudanese refugee children in St. Lukes Sudanese Refugee Network and a Mentor for Burmese refugee families through Jewish Family Services. Larry received his B.A. in Biochemistry (summa cum laude) from Bowdoin College and his M.B.A. from the Anderson School at UCLA.

current job

USA Science & Engineering Festival
USA Science & Engineering Festival

count Of Investments

4

count Of Exists

1

Larry Bock

Employee Profiles
2

Robb Hesley

Director of Business Development

Larry Bock

Larry Bock

Founder & CEO

Activity

Recent News
0